Fig. 2From: Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case reportMalignant melanoma visualized by immunohistochemistry. a High-power view. b Melan-A stain. c S100 stainBack to article page